Technical Analysis for ADIL - Adial Pharmaceuticals, Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.02 | 0.99% | 0.01 |
ADIL closed up 0.99 percent on Wednesday, November 20, 2024, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Flat | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 50 DMA Resistance | Bearish | 0.99% | |
| MACD Bearish Signal Line Cross | Bearish | 0.99% | |
| Calm After Storm | Range Contraction | 0.99% | |
| Narrow Range Bar | Range Contraction | 0.99% | |
| Stochastic Reached Oversold | Weakness | 0.99% | |
| Oversold Stochastic | Weakness | 0.99% |
| Alert | Time |
|---|---|
| Possible NR7 | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
| Down 1% | about 21 hours ago |
| 60 Minute Opening Range Breakout | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The Company has completed a Phase-II clinical trials of AD04.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Alcohol Medication Mental Health Obesity Psychiatry Smoking Drug Products Addiction
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Alcohol Medication Mental Health Obesity Psychiatry Smoking Drug Products Addiction
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.1699 |
| 52 Week Low | 0.765 |
| Average Volume | 148,883 |
| 200-Day Moving Average | 1.28 |
| 50-Day Moving Average | 1.02 |
| 20-Day Moving Average | 1.03 |
| 10-Day Moving Average | 1.04 |
| Average True Range | 0.07 |
| RSI (14) | 49.24 |
| ADX | 22.97 |
| +DI | 28.06 |
| -DI | 13.61 |
| Chandelier Exit (Long, 3 ATRs) | 1.08 |
| Chandelier Exit (Short, 3 ATRs) | 1.17 |
| Upper Bollinger Bands | 1.11 |
| Lower Bollinger Band | 0.95 |
| Percent B (%b) | 0.42 |
| BandWidth | 15.33 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0021 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.06 | ||||
| Resistance 3 (R3) | 1.06 | 1.04 | 1.05 | ||
| Resistance 2 (R2) | 1.04 | 1.03 | 1.04 | 1.05 | |
| Resistance 1 (R1) | 1.03 | 1.02 | 1.03 | 1.03 | 1.05 |
| Pivot Point | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Support 1 (S1) | 1.00 | 1.00 | 1.01 | 1.01 | 0.99 |
| Support 2 (S2) | 0.98 | 0.99 | 0.99 | 0.99 | |
| Support 3 (S3) | 0.97 | 0.98 | 0.99 | ||
| Support 4 (S4) | 0.98 |
